Biktarvy (Bictegravir, Emtricitabine, and Tenofovir Alafenamide)

Product Description

Biktarvy is a prescription medication that combines three active ingredients: Bictegravir, Emtricitabine, and Tenofovir Alafenamide. This medication is specifically designed for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 25 kg.

Active Ingredients

• Bictegravir: 50 mg - an integrase strand transfer inhibitor (INSTI) that helps prevent the virus from multiplying.
• Emtricitabine: 200 mg - a nucleoside reverse transcriptase inhibitor (NRTI) that blocks reverse transcriptase, an enzyme necessary for viral replication.
• Tenofovir Alafenamide: 25 mg - another NRTI that works similarly to Emtricitabine, providing effective viral suppression.

Dosage and Administration

Biktarvy is typically taken once daily with or without food. It is important to follow your healthcare provider's instructions regarding dosage and adherence to the treatment regimen.

Benefits

• Once-daily dosing for convenience.
• Effective in reducing viral load to undetectable levels.
• Well-tolerated with a favorable safety profile.

Potential Side Effects

Common side effects may include nausea, diarrhea, fatigue, and headache. It is essential to contact your healthcare provider if you experience severe side effects or signs of an allergic reaction.

Precautions

Before starting Biktarvy, inform your healthcare provider about any medical conditions, allergies, or medications you are currently taking. Regular monitoring of kidney function and HIV viral load is recommended during treatment.

Storage Instructions

Store Biktarvy at room temperature, away from moisture and heat. Keep out of reach of children and do not use past the expiration date.

Consult Your Healthcare Provider

Always consult your healthcare provider for personalized medical advice and to determine if Biktarvy is the right medication for your HIV treatment plan.